Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
Researchers have developed a simple model system that can be used to break down fibrils -- the cause of numerous disorders including Alzheimer's and Parkinson's disease -- into their constituent ...
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...